m+Medelevator.RU
← Поиск публикаций
Dermatologie (Heidelberg, Germany) · 2026

[Medical care situation of people with vitiligo : A pilot and feasibility study on guideline-oriented management in German dermatology practices].

СтатьяНаблюдательное исследованиеАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mientus Larissa, Sommer Rachel, Steinbrink Kerstin, Böhm Markus

Аннотация

BACKGROUND: Vitiligo is a common chronic disease leading to pigment cell loss in the skin. Despite international consensus recommendations on diagnosis and treatment and the German AWMF S1-guideline published in April 2021, no data exist on the adherence to these recommendations among German dermatologists in private practice. The aim of this pilot project and feasibility study was to obtain preliminary insight into the medical care situation provided by German dermatology practices to people with vitiligo.

METHODS: In a cross-sectional observational study, we addressed 572 dermatologists working in German private practices with a questionnaire on attitude, utilized diagnostic procedures, and prescription of reimbursable therapies.

RESULTS: The majority (53.7%) considered vitiligo a cosmetic problem. Over half (51.1%) of the dermatologists did not use any of the diagnostic methods surveyed, and approximately a quarter (25.6%) did not use any of the therapies surveyed. Dermatologists who regard vitiligo as a serious disease use diagnostic procedures significantly more often and prescribe guideline-based therapies significantly more frequently than those who view vitiligo as a cosmetic issue.

CONCLUSION: Our cross-sectional observational and pilot study suggests a dramatic undertreatment of patients with vitiligo in private practices in Germany. Larger and more detailed studies are needed to confirm our preliminary data. In addition, measures that improve guideline-compliant therapy are required.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты